These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 31566792)
1. Does treatment with propranolol affect quality of life in infantile hemangioma patients and their parents? de Wild SR; Moyakine AV; van der Vleuten CJM Pediatr Dermatol; 2019 Nov; 36(6):958-960. PubMed ID: 31566792 [TBL] [Abstract][Full Text] [Related]
2. Parental experiences with propranolol versus oral corticosteroids for complicated infantile hemangioma, a retrospective questionnaire study. Hermans DJ; Zweegers J; Evers AW; Van Der Vleuten CJ Eur J Dermatol; 2013; 23(6):857-63. PubMed ID: 24185746 [TBL] [Abstract][Full Text] [Related]
3. Influence of infantile hemangioma severity and activity on QoL of patients and their parents: A cross-sectional study. Moyakine AV; Spillekom-van Koulil S; Küpers EM; van der Vleuten CJM Pediatr Dermatol; 2018 Sep; 35(5):628-634. PubMed ID: 30015356 [TBL] [Abstract][Full Text] [Related]
4. Propranolol for treatment of infantile hemangiomas. Melo JN; Rotter A; Rivitti-Machado MC; Oliveira ZN An Bras Dermatol; 2013; 88(6 Suppl 1):220-3. PubMed ID: 24346925 [TBL] [Abstract][Full Text] [Related]
5. Symplastic hemangioma developing over an infantile hemangioma during propranolol treatment. Downey C; Pino G; Zambrano MJ; Kramer D; Cervilla K; González S Pediatr Dermatol; 2019 Nov; 36(6):961-962. PubMed ID: 31468563 [TBL] [Abstract][Full Text] [Related]
6. The Role of the Pharmacist in the Treatment of Patients with Infantile Hemangioma Using Propranolol. Castaneda S; Melendez-Lopez S; Garcia E; De la Cruz H; Sanchez-Palacio J Adv Ther; 2016 Oct; 33(10):1831-1839. PubMed ID: 27461120 [TBL] [Abstract][Full Text] [Related]
7. Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study. Yu Z; Cai R; Chang L; Qiu Y; Chen X; Chen Q; Ma G; Jin Y; Lin X J Dermatol; 2019 May; 46(5):376-382. PubMed ID: 30916822 [TBL] [Abstract][Full Text] [Related]
8. [Infantile hemangioma: a new indication for propranolol? Retrospective study: a case-series of 25 infants]. Yilmaz L; Dangoisse C; Semaille P Rev Med Brux; 2015; 36(1):3-9. PubMed ID: 25856965 [TBL] [Abstract][Full Text] [Related]
9. Initial experiences with propranolol treatment of infantile hemangiomas: report of three cases. Halilbasic A; Hotic N; Husaric E; Rahmanovic E; Halilbasic M; Husaric S Med Arh; 2011; 65(6):380-2. PubMed ID: 22299307 [TBL] [Abstract][Full Text] [Related]
10. Clinical features of cutaneous infantile hemangioma combined with asymptomatic infantile hepatic hemangioma and efficacy of propranolol treatment. Li L; Yu L; Xu Z; Wei L; Zhang B; Han X; Sun Y; Ma L J Cosmet Dermatol; 2023 Dec; 22(12):3369-3374. PubMed ID: 37313653 [TBL] [Abstract][Full Text] [Related]
11. Use of the Hemangioma Severity Scale to facilitate treatment decisions for infantile hemangiomas. Moyakine AV; Herwegen B; van der Vleuten CJM J Am Acad Dermatol; 2017 Nov; 77(5):868-873. PubMed ID: 28818436 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of propranolol in the treatment of infantile hemangioma beyond the proliferation phase. Vivas-Colmenares GV; Bernabeu-Wittel J; Alonso-Arroyo V; Matute de Cardenas JA; Fernandez-Pineda I Pediatr Dermatol; 2015; 32(3):348-52. PubMed ID: 25721095 [TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of VEGF and bFGF in the course of propranolol therapy of infantile hemangioma in children: Are we closer to understand the mechanism of action of propranolol on hemangiomas? Babiak-Choroszczak L; Giżewska-Kacprzak K; Gawrych E; Fischer K; Walecka A; Puchalska-Niedbał L; Rajewska-Majchrzak J; Bagłaj M Adv Clin Exp Med; 2018 May; 27(5):703-710. PubMed ID: 29790692 [TBL] [Abstract][Full Text] [Related]
14. The use of propranolol for complicated infantile hemangiomas. Vercellino N; Romanini MV; Pelegrini M; Rimini A; Occella C; Dalmonte P Int J Dermatol; 2013 Sep; 52(9):1140-6. PubMed ID: 23829783 [TBL] [Abstract][Full Text] [Related]
16. [Infantile hemangioma and propranolol: a therapeutic "revolution". Literature review]. Yilmaz L; Dangoisse C; Semaille P Rev Med Brux; 2013; 34(6):479-84. PubMed ID: 24505868 [TBL] [Abstract][Full Text] [Related]
17. Quality of life in children with infantile hemangioma: a case control study. Wang C; Li Y; Xiang B; Xiong F; Li K; Yang K; Chen S; Ji Y Health Qual Life Outcomes; 2017 Nov; 15(1):221. PubMed ID: 29145889 [TBL] [Abstract][Full Text] [Related]
18. [Propranolol in infantile hemangiomas]. Léauté-Labrèze C Arch Pediatr; 2015 Apr; 22(4):452-5. PubMed ID: 25753275 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis. Mazereeuw-Hautier J; Hoeger PH; Benlahrech S; Ammour A; Broue P; Vial J; Ohanessian G; Léauté-Labrèze C; Labenne M; Vabres P; Rössler J; Bodemer C J Pediatr; 2010 Aug; 157(2):340-2. PubMed ID: 20488455 [TBL] [Abstract][Full Text] [Related]
20. Propranolol for infantile hemangioma (PINCH): an open-label trial to assess the efficacy of propranolol for treating infantile hemangiomas and for determining the decline in heart rate to predict response to propranolol. Sondhi V; Patnaik SK J Pediatr Hematol Oncol; 2013 Oct; 35(7):493-9. PubMed ID: 23929318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]